Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,627 | 228 | 87.1% |
| Travel and Lodging | $743.64 | 2 | 9.8% |
| Education | $237.55 | 4 | 3.1% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,010 | 45 | $0 (2024) |
| NeoTract Inc. | $957.83 | 7 | $0 (2020) |
| Boston Scientific Corporation | $856.36 | 16 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $611.70 | 25 | $0 (2023) |
| PFIZER INC. | $388.51 | 20 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $303.78 | 5 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $241.29 | 4 | $0 (2024) |
| Medtronic, Inc. | $235.57 | 3 | $0 (2024) |
| ABBVIE INC. | $190.27 | 9 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $188.88 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,895 | 49 | Astellas Pharma US Inc ($276.05) |
| 2023 | $1,554 | 57 | Boston Scientific Corporation ($182.50) |
| 2022 | $704.46 | 29 | Boston Scientific Corporation ($210.97) |
| 2021 | $446.31 | 14 | AstraZeneca Pharmaceuticals LP ($123.73) |
| 2020 | $1,096 | 14 | NeoTract Inc. ($913.03) |
| 2019 | $485.21 | 16 | Astellas Pharma US Inc ($189.66) |
| 2018 | $526.31 | 20 | BOSTON SCIENTIFIC CORPORATION ($149.22) |
| 2017 | $901.64 | 36 | Endo Pharmaceuticals Inc. ($193.63) |
All Payment Transactions
235 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 12/26/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 12/05/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $140.44 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 12/05/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: rezum_URO | ||||||
| 11/27/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $126.09 | General |
| Category: UROLOGY | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: Rare Disease | ||||||
| 11/02/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $35.04 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/30/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $19.23 | General |
| Category: Prostate cancer | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Oncology | ||||||
| 10/11/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $27.79 | General |
| 10/09/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Urology Gynecology | ||||||
| 09/30/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $123.69 | General |
| Category: HORMONE THERAPY | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.38 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/04/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $22.72 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 08/28/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $42.53 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 08/20/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Oncology | ||||||
| 08/19/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/06/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Rare Disease | ||||||
| 08/02/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $48.42 | General |
| Category: Urology | ||||||
| 08/01/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $8.32 | General |
| Category: Urology | ||||||
| 07/31/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/30/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $23.24 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,738 | 4,253 | $258,538 | $162,447 |
| 2022 | 19 | 2,298 | 3,229 | $219,394 | $138,845 |
| 2021 | 13 | 2,068 | 2,857 | $146,840 | $93,013 |
| 2020 | 13 | 1,670 | 2,172 | $123,540 | $76,992 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 429 | 585 | $79,539 | $51,272 | 64.5% |
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 15 | 630 | $47,506 | $37,244 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 260 | $24,679 | $16,172 | 65.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 108 | 108 | $19,600 | $11,652 | 59.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 11 | 72 | $13,430 | $9,990 | 74.4% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 11 | 11 | $18,492 | $5,798 | 31.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 527 | 724 | $8,236 | $5,505 | 66.8% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 387 | 507 | $7,540 | $4,954 | 65.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 42 | 92 | $5,912 | $4,635 | 78.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 58 | 67 | $17,257 | $4,052 | 23.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 294 | 358 | $2,958 | $2,860 | 96.7% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 22 | 22 | $5,505 | $2,297 | 41.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $2,896 | $1,934 | 66.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 514 | 700 | $1,622 | $1,537 | 94.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 12 | 12 | $921.84 | $722.76 | 78.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 22 | 29 | $1,012 | $700.42 | 69.2% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 22 | 22 | $725.34 | $568.70 | 78.4% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 17 | 17 | $532.61 | $417.52 | 78.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 12 | $174.60 | $136.92 | 78.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 324 | 435 | $58,814 | $37,373 | 63.5% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2022 | 12 | 12 | $38,159 | $30,046 | 78.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 23 | 189 | $37,831 | $26,999 | 71.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 203 | 269 | $25,640 | $16,272 | 63.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 63 | 63 | $10,948 | $5,699 | 52.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 437 | 617 | $6,929 | $4,573 | 66.0% |
About Dr. Gregory Hester, MD
Dr. Gregory Hester, MD is a Urology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508952870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Hester, MD has received a total of $7,608 in payments from pharmaceutical and medical device companies, with $1,895 received in 2024. These payments were reported across 235 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($6,627).
As a Medicare-enrolled provider, Hester has provided services to 8,774 Medicare beneficiaries, totaling 12,511 services with total Medicare billing of $471,297. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Houston, TX
- Active Since 10/05/2006
- Last Updated 05/22/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1508952870
Products in Payments
- UroLift (Device) $935.83
- SpaceOAR VUE System - 10mL (Device) $567.71
- XIAFLEX (Biological) $419.97
- Xtandi (Drug) $392.96
- INTERSTIM (Device) $294.41
- XTANDI (Drug) $289.74
- PROVENGE (Drug) $209.37
- Myrbetriq (Drug) $195.23
- AVEED (Biological) $191.73
- AQUABEAM SYSTEM (Device) $187.46
- ADSTILADRIN (Biological) $173.65
- Bard Urinary Drainage Bag (Device) $173.42
- ORGOVYX (Drug) $166.16
- LUPRON DEPOT (Drug) $154.84
- GENERAL FEMALE SUI (Device) $149.22
- KEYTRUDA (Biological) $145.18
- MYRBETRIQ (Drug) $140.47
- NOCDURNA (Drug) $129.56
- PROLARIS (Device) $125.66
- PYLARIFY (Drug) $119.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Houston
Donald Griffith, Md, MD
Urology — Payments: $954,139
Mohit Khera, M.d, M.D
Urology — Payments: $412,879
Dr. Jonathan Clavell Hernandez, Md, MD
Urology — Payments: $402,131
Ashish Kamat, M.d, M.D
Urology — Payments: $395,016
Run Wang, M.d, M.D
Urology — Payments: $277,432
Ouida Westney, M.d, M.D
Urology — Payments: $250,571